Knight Therapeutics Inc to Post Q1 2019 Earnings of $0.02 Per Share, Cormark Forecasts (GUD) Fairfield Current
Knight Therapeutics Inc (TSE:GUD) – Equities research analysts at Cormark reduced their Q1 2019 earnings per share (EPS) estimates for shares of Knight …